ArticleInternational journal of medical sciences2021

Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study.

Sheng-Wen Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.